Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Molecular Imaging and Biology|September 10, 2020
ImmunoPET Imaging of Pancreatic Tumors with 89Zr-Labeled Gold Nanoparticle-Antibody ConjugatesNicholas B Sobol, Joshua A Korsen, Ali Younes, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 6, 2021
Influence of Fc Modifications and IgG Subclass on Biodistribution of Humanized Antibodies Targeting L1CAMSai Kiran Sharma, Maya Suzuki, Hong Xu, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 23, 2024
CEACAM5-Targeted Immuno-PET in Androgen Receptor-Negative Prostate CancerCinzia Imberti, Roberto De Gregorio, Joshua A Korsen, et al.Nature Communications|August 11, 2019
Synthetic molecular recognition nanosensor paint for microalbuminuriaJanuka Budhathoki-Uprety, Janki Shah, Joshua A Korsen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 21, 2022
Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3Joshua A Korsen, Teja M Kalidindi, Samantha Khitrov, et al.Proceedings of the National Academy of Sciences of the United States of America|June 27, 2022
Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancerJoshua A Korsen, Julia A Gutierrez, Kathryn M Tully, et al.Bioconjugate Chemistry|April 9, 2021
Synthesis and Comparative In Vivo Evaluation of Site-Specifically Labeled Radioimmunoconjugates for DLL3-Targeted ImmunoPETSai Kiran Sharma, Pierre Adumeau, Outi Keinänen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low ToxicityKathryn M Tully, Salomon Tendler, Lukas M Carter, et al.Proceedings of the National Academy of Sciences of the United States of America|February 2, 2026
Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancersSalomon Tendler, Roberto De Gregorio, Paul Balderes, et al.Nature Cancer|April 10, 2023
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancerMartin K Bakht, Yasutaka Yamada, Sheng-Yu Ku, et al.Pageof 1